COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Innovations’ Venerate Biopesticide Named Best New Biological Product at Agrow Awards 2018 in London
13/11/2018
DAVIS, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that Agribusiness [...]
Cellectar Reports Third Quarter 2018 Financial Results and Provides Business Update
13/11/2018
FLORHAM PARK, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (“Cellectar” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and [...]
MedTainer Issues Great Q: North American Picture Emerges
13/11/2018
CORONA, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- MedTainer™ Inc. (MDTR-OTCMARKETS) published their 3 rd Quarter 10-Q today and report that gross sales in the quarter have increased approximately 22% compared to 3 rd [...]
NexTech AR Brings Augmented Reality to Cannabis -- CFN Media
13/11/2018
SEATTLE, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
New Data Demonstrates Clinical Utility of Daxor Corporation’s Blood Volume Analyzer (BVA-100) in Evaluation of Hypertension
13/11/2018
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]
Lexaria Targets Cannabinoids, Tobacco, Hemp, and Pharma Markets with New Subsidiaries -- CFN Media
13/11/2018
SEATTLE, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
PSIQ Reports Record Breaking September 30th, 2018 Nine Month Revenue Increase of 850%
13/11/2018
SUNRISE, Fla., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), reported revenues for the nine [...]
Micron Solutions, Inc. Reports 2018 Third Quarter Results
13/11/2018
FITCHBURG, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
Medtronic Receives CE Mark Approval for the Valiant Navion(TM) Thoracic Stent Graft System
13/11/2018
Lower-Profile Thoracic Endovascular Aortic Repair (TEVAR) Device Broadens Treatable Patient Population with Thoracic Aortic Disease DUBLIN - November 13, 2018 - Medtronic plc (NYSE:MDT) today announced it has received [...]
Iovance Biotherapeutics to Participate at November Investor Conferences
13/11/2018
SAN CARLOS, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]
assessURhealth™ named Tampa Bay Tech’s 2018 Emerging Technology Company of the Year
13/11/2018
The disruptive health IT company honored for innovative mental & behavioral health screening technology Tampa, FL, Nov. 13, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC , a leading provider of electronic mental and [...]
Apellis Pharmaceuticals Reports Third Quarter 2018 Business Update and Financial Results
13/11/2018
- Commenced Phase 3 Program of APL-2 in Geographic Atrophy (GA) - - Cash Position of $220.6 Million at Quarter-End - CRESTWOOD, Ky. and CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. ( [...]
CymaBay Therapeutics Presents Positive Results from its Ongoing Phase 2 Study of Seladelpar in Patients with PBC at The Liver Meeting® 2018
13/11/2018
Sustained anti-cholestatic and anti-inflammatory effects observed with no worsening of pruritus through 52 weeks Results highlight the potential for seladelpar to offer patients an efficacious and safe second line [...]
Forty Seven Inc. Reports Third Quarter 2018 Financial Results and Recent Business Highlights
13/11/2018
-- Advanced Oncology Pipeline with FSI-189, an Anti-SIRPα Antibody; Investigational New Drug (IND) Application-Enabling Studies Expected to Begin in 2019 – -- New England Journal of Medicine Published Data from Phase 1b [...]
Brainsway Reports Financial Results for Third Quarter of 2018 and Provides Corporate Update
13/11/2018
Third quarter revenues of $4.3 million represent quarterly record and 42% increase over third quarter 2017 Recently commenced installing Deep TMS system for treatment of OCD at U.S. Sites HACKENSACK, N.J., Nov. 13, 2018 [...]
LogicBio to Present at the Jefferies 2018 London Healthcare Conference
13/11/2018
CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet [...]
InspireMD Announces Upcoming Presentations at the 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium)
13/11/2018
TEL AVIV, Israel, Nov. 13, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery [...]
BioSig Technologies Announces New Research Program with Mayo Clinic
13/11/2018
New Agreement to Focus on Enhanced Features of PURE EP System and Future Potential Clinical Applications Santa Monica, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device [...]
Rubius Therapeutics Reports Third Quarter 2018 Financial Results and Operational Progress
13/11/2018
On Track to Submit First IND for RTX-134 in Q1 2019 CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company developing an entirely new class of allogeneic [...]

Pages